Early-onset Parkinson's disease due to PINK1 p.Q456X mutation--clinical and functional study.

@article{Siuda2014EarlyonsetPD,
  title={Early-onset Parkinson's disease due to PINK1 p.Q456X mutation--clinical and functional study.},
  author={Joanna Siuda and Barbara Jasińska-Myga and Magdalena Boczarska-Jedynak and Grzegorz M Opala and Fabienne C. Fiesel and Elisabeth L. Moussaud-Lamodi{\`e}re and Leslie Scarffe and Valina L. Dawson and Owen A. Ross and Wolfdieter Springer and Ted M. Dawson and Zbigniew K. Wszolek},
  journal={Parkinsonism \& related disorders},
  year={2014},
  volume={20 11},
  pages={
          1274-8
        }
}

Figures and Tables from this paper

Heterozygous PINK1 p.G411S increases risk of Parkinson’s disease via a dominant-negative mechanism
TLDR
Based on genetic and clinical evaluation as well as functional and structural characterization, the p.G411S mutation interferes with ubiquitin phosphorylation by wild-type PINK1 in a heterodimeric complex and impairs the protective functions of the Pink1/parkin-mediated mitochondrial quality control.
PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
TLDR
The effect of mutations in 11 PARK genes on mitochondrial function as well as their relevance in the formation of Lewy pathology suggest rectifying mitochondrial dysregulation represents a promising therapeutic approach for neuroprotection in PD.
Analysis of copy number variation and disease mechanisms underlying Parkinson’s disease
TLDR
A cellular model of PD was created by decreasing the expression of PINK1 in SH-SY5Y neuroblastoma cells and the protective effects of curcumin was tested on this model in the presence and absence of a known stressor, paraquat.
The PINK1 p.I368N Mutation Affects Protein Stability and Kinase Activity with Its Structural Change
TLDR
This study revealed two mechanisms that lead to loss of function of PINK1 upon mutation and investigated molecular mechanisms on the structural and functional level in patientsʼ fibroblasts and in cell-based, biochemical assays.
Analysis of a murine Pink1 deficiency in serotonergic and dopaminergic neurons in respect of Parkinson´s disease
TLDR
The serotonergic and dopaminergic system potentially plays a role in the development of PD-related non-motor symptoms upon Pink1 deficiency, as well as uncovering possible compensatory mechanisms.
Evidence of Neurobiological Changes in the Presymptomatic PINK1 Knockout Rat.
TLDR
Early markers of presymptomatic PD in the PINK1 -/- rat at 3 months are identified using magnetic resonance imaging techniques, and novel brain regions involved in the pathology of PD are highlighted before behavioral dysfunction occurs.
The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity
TLDR
It is demonstrated that mutant PINK1 p.I368N can not be stabilized on the OMM upon mitochondrial stress and due to conformational changes in the active site does not exert kinase activity towards Ub, highlighting potential strategies for future drug development.
Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson’s Disease
TLDR
It is of paramount importance to further define the role of PINK1 in mitophagy and mitochondrial homeostasis in PD pathogenesis in order to delineate novel therapeutic targets.
Nonmotor Signs in Genetic Forms of Parkinson's Disease.
...
...

References

SHOWING 1-10 OF 13 REFERENCES
Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?
TLDR
Long-term follow-up of a large family W provides an excellent opportunity to further evaluate the role of single heterozygous PINK1 mutations later in life, which will have major implications on genetic counseling.
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.
TLDR
It is suggested that PINK1 is the second most frequent causative gene in early-onset Parkinson's disease with a slowly progressive phenotype, indistinguishable from early-ONSet patients with parkin mutations.
PINK1 mutations and parkinsonism
TLDR
Segregation of Pink1 mutations with parkinsonism within families, and frequency estimates within population controls, suggested only four PINK1 mutations were pathogenic.
Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients.
TLDR
The frequency of the PARK2, PINK1, PARK7 mutations among Polish EO-PD patients seems to be low, and the role of single heterozygous mutations remains a matter of debate and needs further investigations.
A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease
TLDR
Clinical differences between LRRK2, PINK1 and genetically undefined familial PD appear more pronounced than previously appreciated, and may prove useful in clinical practice.
Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes
TLDR
PINK1 homozygous mutations are a relevant cause of disease among Italian sporadic patients with early-onset parkinsonism, and this study suggests that, at least in some patients, these mutations are disease causing, in combination with additional, still unknown factors.
Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease
TLDR
Fibroblasts from PINK1 mutation patients had significant defects of bioenergetics including reduced mitochondrial membrane potential, altered redox state, a respiratory deficiency that was determined by substrate availability, and enhanced sensitivity to calcium stimulation and associated mitochondrial permeability pore opening.
Systematic Review and UK‐Based Study of PARK2 (parkin), PINK1, PARK7 (DJ‐1) and LRRK2 in early‐onset Parkinson's disease
TLDR
This study screened 136 EOPD probands from a high‐ascertainment regional and community‐based prevalence study for pathogenic mutations in PARK2 (parkin), PINK1, PARK7 (DJ‐1), and exon 41 of LRRK2 and shows an increased likelihood of mutations in patients with lower AAO, family history, or parental consanguinity.
...
...